At a glance
ClinicalIndex Comparison RecordN/ACompleted· 275 enrolled
Drug / intervention
etafilcon A control lens (1DM) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Validation of Etafilcon A With Print and PVP Contact Lenses for Dark Eyes and Light Eyes
In Brief
A clinical study evaluating etafilcon A control lens (1DM), etafilcon A with print and PVP for light eyes (EALE), and 1 other intervention for Refractive Ametropia. Completed, enrolled 275 participants across 15 sites.
Detailed Summary
This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Ametropia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedDec 2011
Primary CompletionFeb 2012
TodayJul 2026
First PostedDec 2, 2011
Enrollment StartNov 1, 2011
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.6 years ago
Interventions
etafilcon A control lens (1DM)device
A marketed daily disposable contact lens
etafilcon A with print and PVP for light eyes (EALE)device
A daily disposable contact lens
etafilcon A with print and PVP for dark eyes (EADE)device
A daily disposable contact lens